Twitxy Saved

Community Health Media

Verified account This account is verified. Learn more

@CHMediaHub

Medical education through expert conversations 🧬Podcasts, Interviews and Programs for clinicians 🩻 “Medicine Moves Through Shared Knowledge."
linktr.ee/CommunityHealt… Joined October 2024
318 Following 184 Followers 612 Posts

Latest posts 5

Community Health Media Verified account @CHMediaHub
Acting on a resistance mutation before the scan shows progression? SERENA-6 tested exactly that.
Dr. Sarah Sammons (@drsarahsam) explains why acting on ESR1 early, before radiographic progression, is a new strategy and why it works. In the trial, switching to camizestrant at ESR1 detection prolonged progression-free survival, helping patients stay on first-line therapy longer.
Swipe through to see what it means for your practice ➡️

🎥 Watch the full conversation with Drs. Neil Iyengar (@Neil_Iyengar), Sarah Sammons & Tiffany Traina: communityhealth.media/serena-6-esr1-…

💬 Would you switch therapy on a ctDNA result alone?
Community Health Media Verified account @CHMediaHub
Your patient's ctDNA shows an ESR1 mutation, but her scans are stable. Do you switch now or wait?

SERENA-6 put that question on every breast oncologist's desk. Drs. Sarah Sammons (@drsarahsam), Tiffany Traina and Neil Iyengar (@Neil_Iyengar) discuss the case for acting early in HR+/HER2− metastatic breast cancer: switching to camizestrant while continuing the same CDK4/6 inhibitor. They point out that patients who clear ctDNA do better.
The overall survival question is still open. But the panel argues that the secondary endpoints and quality-of-life data already lean toward switching early, and that could change how you use ctDNA monitoring in practice.

🎥 Watch the full SERENA-6 discussion: communityhealth.media/serena-6-esr1-…
💬 Are you acting on ESR1 mutations found on ctDNA, or waiting for radiographic progression?
0:50
Community Health Media Verified account @CHMediaHub
How did pneumonitis go from a major worry to a success story with T-DXd?

Dr. Seth Wander tells Dr. Paolo Tarantino (@PTarantinoMD) how the original phase 2 data in treatment-refractory HER2-positive breast cancer showed higher rates of higher-grade pneumonitis.
Clinicians then started anticipating it. Through the phase 3 data in the second line, and now in the adjuvant and first-line settings, the grades of pneumonitis have shifted lower. The reason is vigilance: clinicians know it can happen, so they watch for it on CT and intervene before any clinical symptoms or problems with oxygenation.

He calls it a huge success story, though pneumonitis still happens and close CT monitoring is key.

🎥 Watch the full conversation: communityhealth.media/tdxd-her2-posi…

💬 How often do you image patients on T-DXd to catch ILD early?
0:53
Community Health Media Verified account @CHMediaHub
Is endocrine monotherapy on its way out now that targeted therapy combinations are arriving for ESR1-mutated disease?

Dr. Erika Hamilton (@ErikaHamilton9) tells Dr. Jason Mouabbi (@JAMouabbi) she doesn’t think so. She agrees that combinations can deliver a longer PFS. But many patients do really well on monotherapy, and its tolerability is hard to beat.

When would she consider a combination? She looks for certain clinical features: a short time on the last endocrine therapy, a short time on a CDK4/6 inhibitor, or a high burden of liver disease. For the many patients with an ESR1 mutation who are doing well on monotherapy, she says that’s a stretch of really good quality of life she wouldn’t want to give up.

🎥 Watch the full conversation: communityhealth.media/series/mouabbi…

💬 Which clinical features push you toward a combination over monotherapy?
1:01
Community Health Media Verified account @CHMediaHub
We are growing fast and we are looking for a Senior Vice President, Medical to serve as a senior leader on our medical team. Working directly with our Head of Medical Affairs, you will help oversee the medical team and own the scientific substance of our programs, from first talking points and discussion guides to slide decks, final content review, and on-site support at shoots and congresses.

indeed.com/m/viewjob?jk=e…
www.indeed.com Senior Vice President, Medical - Remote - Indeed.com Apply for the Senior Vice President, Medical remote job! Learn more about the job description, salary, and job details to see if you qualify on Indeed today.